Nuwellis Secures $6M in Highly Dilutive Offering, Issues Warrants
NUWE is trading near its 52-week low of $0.132 (13% above the low) on elevated volume (4.4× avg).
Summary
Nuwellis has officially closed its registered public offering, raising $6.0 million in gross proceeds. This critical financing involved the issuance of common stock, pre-funded warrants, and substantial Series C and D warrants. The closing provides immediate liquidity for the financially distressed company, which has been operating under a "going concern" warning and reported widening losses. However, the offering is highly dilutive; following the exercise of pre-funded warrants, the company will have 12,750,321 shares outstanding. This follows multiple SEC filings over the past month detailing the offering, which was finalized for $6.0 million on June 8th.
At the time of this announcement, NUWE was trading at $0.15 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $389.2K. The 52-week trading range was $0.13 to $25.95. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.